FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martijn Gebbink

Research Profile

Living Beings

Chemicals & Drugs

Phenomena

Protein Binding

Physiology

Disorders

Neovascularization, Pathologic

Co-author Network

Publications

TOP 3
Brian O'Nuallain; Michael J Rowan; Alfred Welzel; Andrew Barry; James P Cleary; Richard K Dykoski; James S Foster; Martijn F B G Gebbink; Igor Klyubin; Jessica M Mc Donald; Dominic M Walsh
A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain-derived synaptic plasticity-disrupting Aβ.
Martijn F B G Gebbink; Barend Bouma; Coen Maas; Bonno N Bouma
Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors).
Wieke Teertstra; Gisela J van der Velden; Jan F de Jong; John A W Kruijtzer; Rob M J Liskamp; Loes M J Kroon-Batenburg; Wally H Müller; Martijn F B G Gebbink; Han A B Wösten
The filament-specific Rep1-1 repellent of the phytopathogen Ustilago maydis forms functional surface-active amyloid-like fibrils.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martijn Gebbink (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Brian O'Nuallain; Michael J Rowan; Alfred Welzel; Andrew Barry; James P Cleary; Richard K Dykoski; James S Foster; Martijn F B G Gebbink; Igor Klyubin; Jessica M Mc Donald; Dominic M Walsh
A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain-derived synaptic plasticity-disrupting Aβ.
Journal of neurochemistry 2011;119(1):189-201.
2009: Martijn F B G Gebbink; Barend Bouma; Coen Maas; Bonno N Bouma
Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors).
FEBS letters 2009;583(16):2691-9.
2009: Wieke Teertstra; Gisela J van der Velden; Jan F de Jong; John A W Kruijtzer; Rob M J Liskamp; Loes M J Kroon-Batenburg; Wally H Müller; Martijn F B G Gebbink; Han A B Wösten
The filament-specific Rep1-1 repellent of the phytopathogen Ustilago maydis forms functional surface-active amyloid-like fibrils.
The Journal of biological chemistry 2009;284(14):9153-9.
2008: Coen Maas; Bettina Schiks; Remo D Strangi; Tilman M Hackeng; Bonno N Bouma; Martijn F B G Gebbink; Barend Bouma
Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2008;15(3):166-80.
2008: Coen Maas; José W P Govers-Riemslag; Barend Bouma; Bettina Schiks; Bouke P C Hazenberg; Henk M Lokhorst; Per Hammarström; Hugo ten Cate; Philip G de Groot; Bonno N Bouma; Martijn F B G Gebbink
Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.
The Journal of clinical investigation 2008;118(9):3208-18.
2008: Eszter Herczenik; Martijn F B G Gebbink
Molecular and cellular aspects of protein misfolding and disease.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(7):2115-33.
2007: Eszter Herczenik; Barend Bouma; Suzanne J A Korporaal; Remo Strangi; Qinghong Zeng; Piet Gros; Miranda van Eck; Theo Van berkel; Martijn F B G Gebbink; Jan-Willem N Akkerman
Activation of human platelets by misfolded proteins.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(7):1657-65.
2007: Barend Bouma; Coen Maas; Bouke P C Hazenberg; Henk M Lokhorst; Martijn F B G Gebbink
Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses.
Journal of thrombosis and haemostasis : JTH 2007;5(6):1139-42.
2007: Coen Maas; Suzanne Hermeling; Barend Bouma; Wim Jiskoot; Martijn F B G Gebbink
A role for protein misfolding in immunogenicity of biopharmaceuticals.
The Journal of biological chemistry 2007;282(4):2229-36.
2006: Suzanne Hermeling; Huub Schellekens; Coen Maas; Martijn F B G Gebbink; Daan J A Crommelin; Wim Jiskoot
Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation.
Journal of pharmaceutical sciences 2006;95(5):1084-96.
2006: Dieta Brandsma; Laurien H Ulfman; Jaap C Reijneveld; Madelon Bracke; Martin J B Taphoorn; Jaap-Jan Zwaginga; Martijn F B G Gebbink; Hetty de Boer; Leo Koenderman; Emile E Voest
Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases.
Neuro-oncology 2006;8(2):127-36.
2006: Virginie Terraube; Ronan Pendu; Dominique Baruch; Martijn F B G Gebbink; D Meyer; Peter J Lenting; Cécile V Denis
Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice.
Journal of thrombosis and haemostasis : JTH 2006;4(3):519-26.
2005: Martijn F B G Gebbink; Dennis Claessen; Barend Bouma; Lubbert Dijkhuizen; Han A B Wösten
Amyloids--a functional coat for microorganisms.
Nature reviews. Microbiology 2005;3(4):333-41.
2005: Onno Kranenburg; Barend Bouma; Yoony Y J Gent; Colinda J Aarsman; Rakez Kayed; George Posthuma; Bettina Schiks; Emile E Voest; Martijn F B G Gebbink
Beta-amyloid (Abeta) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation.
Molecular and cellular neurosciences 2005;28(3):496-508.
2005: Elianne A Koop; Martijn F B G Gebbink; Terrence E Sweeney; Marie-Jeanne Mathy; Harry F G Heijnen; Jos A E Spaan; Emile E Voest; Ed VanBavel; Stephan L M Peters
Impaired flow-induced dilation in mesenteric resistance arteries from receptor protein tyrosine phosphatase-mu-deficient mice.
American journal of physiology. Heart and circulatory physiology 2005;288(3):H1218-23.
2005: Elisabeth A te Velde; Arie Reijerkerk; Dieta Brandsma; J Mathijs Vogten; Y Wu; Onno Kranenburg; Emile E Voest; Martijn F B G Gebbink; Inne H M Borel Rinkes
Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells.
British journal of cancer 2005;92(4):729-35.
2005: Onno Kranenburg; Y Y J Gent; Edwin Romijn; Emile E Voest; albert heck; Martijn F B G Gebbink
Amyloid-beta-stimulated plasminogen activation by tissue-type plasminogen activator results in processing of neuroendocrine factors.
Neuroscience 2005;131(4):877-86.
2004: Henk B Kal; Henk Struikmans; Martijn F B G Gebbink; Emile E Voest
Response of rat prostate and lung tumors to ionizing radiation combined with the angiogenesis inhibitor AMCA.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2004;180(12):798-804.
2004: Martijn F B G Gebbink; Emile E Voest; Arie Reijerkerk
Do antiangiogenic protein fragments have amyloid properties?
Blood 2004;104(6):1601-5.
2004: Haiko J Bloemendal; Hetty C de Boer; Elianne A Koop; Alice J van Dongen; roel goldschmeding; Wil Landman; Ton Logtenberg; Martijn F B G Gebbink; Emile E Voest
Activated vitronectin as a target for anticancer therapy with human antibodies.
Cancer immunology, immunotherapy : CII 2004;53(9):799-808.
2004: Ya-Ping Wu; Haiko J Bloemendal; Emile E Voest; Ton Logtenberg; Philip G de Groot; Martijn F B G Gebbink; Hetty C de Boer
Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin.
Blood 2004;104(4):1034-41.
2004: Arie Reijerkerk; Joost C M Meijers; Stefan R Havik; Bonno N Bouma; Emile E Voest; Martijn F B G Gebbink
Tumor growth and metastasis are not affected in thrombin-activatable fibrinolysis inhibitor-deficient mice.
Journal of thrombosis and haemostasis : JTH 2004;2(5):769-79.
2004: Onno Kranenburg; Martijn F B G Gebbink; Emile E Voest
Stimulation of angiogenesis by Ras proteins.
Biochimica et biophysica acta 2004;1654(1):23-37.
2004: Hans A R Bluyssen; Martijn Lolkema; Moniek van Beest; Michelle Boone; Cristel M J T Snijckers; Maartje Los; Martijn F B G Gebbink; Branko Braam; Frank C P Holstege; Rachel H Giles; Emile E Voest
Fibronectin is a hypoxia-independent target of the tumor suppressor VHL.
FEBS letters 2004;556(1-3):137-42.
2004: Laurens V Beerepoot; Niven Mehra; J S P Vermaat; Bernard A Zonnenberg; Martijn F B G Gebbink; Emile E Voest
Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(1):139-45.
2003: Tom A Drixler; J Mathijs Vogten; Martijn F B G Gebbink; Peter Carmeliet; Emile E Voest; Inne H M Borel Rinkes
Plasminogen mediates liver regeneration and angiogenesis after experimental partial hepatectomy.
The British journal of surgery 2003;90(11):1384-90.
2003: Barend Bouma; Loes M J Kroon-Batenburg; Ya-Ping Wu; Bettina Brünjes; George Posthuma; Onno Kranenburg; Philip G de Groot; Emile E Voest; Martijn F B G Gebbink
Glycation induces formation of amyloid cross-beta structure in albumin.
The Journal of biological chemistry 2003;278(43):41810-9.
2003: Elisabeth A te Velde; G T M Wagenaar; Arie Reijerkerk; M Roose-Girma; Inne H M Borel Rinkes; Emile E Voest; Bonno N Bouma; Martijn F B G Gebbink; Joost C M Meijers
Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor.
Journal of thrombosis and haemostasis : JTH 2003;1(10):2087-96.
2003: Laurens V Beerepoot; Els O Witteveen; Gerard Groenewegen; William E Fogler; B Kim Lee Sim; Carolyn Sidor; Bernard A Zonnenberg; Franz Schramel; Martijn F B G Gebbink; Emile E Voest
Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4025-33.
2003: Jacqueline Mulder; Mieke Poland; Martijn F B G Gebbink; Jero Calafat; Wouter H Moolenaar; Onno Kranenburg
p116Rip is a novel filamentous actin-binding protein.
The Journal of biological chemistry 2003;278(29):27216-23.
2003: Ben N G Giepmans; Elles Feiken; Martijn F B G Gebbink; Wouter H Moolenaar
Association of connexin43 with a receptor protein tyrosine phosphatase.
Cell communication & adhesion 2003;10(4-6):201-5.
2003: Elianne A Koop; Susana M Chuva de Sousa Lopes; Elles Feiken; Hans A R Bluyssen; Martin van der Valk; Emile E Voest; Christine L Mummery; Wouter H Moolenaar; Martijn F B G Gebbink
Receptor protein tyrosine phosphatase mu expression as a marker for endothelial cell heterogeneity; analysis of RPTPmu gene expression using LacZ knock-in mice.
The International journal of developmental biology 2003;47(5):345-54.
2003: Arie Reijerkerk; Laurent O Mosnier; Onno Kranenburg; Bonno N Bouma; Peter Carmeliet; Tom A Drixler; Joost C M Meijers; Emile E Voest; Martijn F B G Gebbink
Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system.
Molecular cancer research : MCR 2003;1(8):561-8.
2003: Onno Kranenburg; Loes M J Kroon-Batenburg; Arie Reijerkerk; Ya-Ping Wu; Emile E Voest; Martijn F B G Gebbink
Recombinant endostatin forms amyloid fibrils that bind and are cytotoxic to murine neuroblastoma cells in vitro.
FEBS letters 2003;539(1-3):149-55.
2003: J Mathijs Vogten; Arie Reijerkerk; Joost C M Meijers; Emile E Voest; Inne H M Borel Rinkes; Martijn F B G Gebbink
The role of the fibrinolytic system in corneal angiogenesis.
Angiogenesis 2003;6(4):311-6.
2002: Tom A Drixler; Mathys J Vogten; Ewan D Ritchie; Th J M V van Vroonhoven; Martijn F B G Gebbink; Emile E Voest; Inne H M Borel Rinkes
Liver regeneration is an angiogenesis- associated phenomenon.
Annals of surgery 2002;236(6):703-11; discussion 711-2.
2002: Dieta Brandsma; Jaap C Reijneveld; Martin J B Taphoorn; Hetty C de Boer; Martijn F B G Gebbink; Laurien H Ulfman; Jaap-Jan Zwaginga; Emile E Voest
Vascular cell adhesion molecule-1 is a key adhesion molecule in melanoma cell adhesion to the leptomeninges.
Laboratory investigation; a journal of technical methods and pathology 2002;82(11):1493-502.
2002: Onno Kranenburg; Barend Bouma; Loes M J Kroon-Batenburg; Arie Reijerkerk; Ya-Ping Wu; Emile E Voest; Martijn F B G Gebbink
Tissue-type plasminogen activator is a multiligand cross-beta structure receptor.
Current biology : CB 2002;12(21):1833-9.
2002: Elisabeth A te Velde; J Mathijs Vogten; Martijn F B G Gebbink; J M van Gorp; Emile E Voest; Inne H M Borel Rinkes
Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model.
The British journal of surgery 2002;89(10):1302-9.
2002: Elisabeth A te Velde; Emile E Voest; Joost M van Gorp; André Verheem; Jeroen Hagendoorn; Martijn F B G Gebbink; Inne H M Borel Rinkes
Adverse effects of the antiangiogenic agent angiostatin on the healing of experimental colonic anastomoses.
Annals of surgical oncology 2002;9(3):303-9.
2001: Tom A Drixler; Inne H M Borel Rinkes; Ewan D Ritchie; F W Treffers; Th J M V van Vroonhoven; Martijn F B G Gebbink; Emile E Voest
Angiostatin inhibits pathological but not physiological retinal angiogenesis.
Investigative ophthalmology & visual science 2001;42(13):3325-30.
2000: Arie Reijerkerk; Emile E Voest; Martijn F B G Gebbink
No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer.
European journal of cancer (Oxford, England : 1990) 2000;36(13 Spec No):1695-705.
2000: Elles Feiken; I van Etten; Martijn F B G Gebbink; Wouter H Moolenaar; GC Zondag
Intramolecular interactions between the juxtamembrane domain and phosphatase domains of receptor protein-tyrosine phosphatase RPTPmu. Regulation of catalytic activity.
The Journal of biological chemistry 2000;275(20):15350-6.
2000: Tom A Drixler; Inne H M Borel Rinkes; Ewan D Ritchie; Th J M V van Vroonhoven; Martijn F B G Gebbink; Emile E Voest
Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy.
Cancer research 2000;60(6):1761-5.
2000: Pauline F Marx; G T M Wagenaar; Arie Reijerkerk; M J Tiekstra; A G van Rossum; Martijn F B G Gebbink; Joost C M Meijers
Characterization of mouse thrombin-activatable fibrinolysis inhibitor.
Thrombosis and haemostasis 2000;83(2):297-303.
1999: Maartje Los; S Zeamari; J A Foekens; Martijn F B G Gebbink; Emile E Voest
Regulation of the urokinase-type plasminogen activator system by the von Hippel-Lindau tumor suppressor gene.
Cancer research 1999;59(17):4440-5.
1997: Onno Kranenburg; Mieke Poland; Martijn F B G Gebbink; Lauran Oomen; Wouter H Moolenaar
Dissociation of LPA-induced cytoskeletal contraction from stress fiber formation by differential localization of RhoA.
Journal of cell science 1997;110 ( Pt 19)():2417-27.
1997: Martijn F B G Gebbink; Onno Kranenburg; Mieke Poland; Francis P G van Horck; B Houssa; Wouter H Moolenaar
Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: control of neuronal morphology.
The Journal of cell biology 1997;137(7):1603-13.